Low Pulmonary Artery Pulsatility Index May Identify High Risk for Cardiovascular Disease
Researchers examined the relationship between pulmonary artery pulsatility index and multiple adverse outcomes in patients at risk for cardiovascular disease.
Researchers examined the relationship between pulmonary artery pulsatility index and multiple adverse outcomes in patients at risk for cardiovascular disease.
A prospective registry study evaluated the prognostic value of multiple pulmonary hemodynamic variables for risk prediction in PH-LHD.
The purpose of this study was to determine whether baseline pulmonary hypertension influences the outcome of transcatheter mitral valve repair (TMVr) in patients presenting with HF with SMR.
No causal association between elevated red cell distribution width and pulmonary arterial hypertension was established.
Similar to results among people who smoked traditional cigarettes, e-cigarette smoking negatively effects heart disease risk factors, namely, cholesterol, triglycerides and glucose levels, and decreases blood flow in the heart.
Patients who received thrombolysis during cardiopulmonary resuscitation for out-of-hospital cardiac arrest with confirmed pulmonary embolism had significantly higher 30-day survival rates vs patients who did not receive thrombolysis.
The FDA gave approval to market Sildenafil for Oral Suspension, 10mg/mL, a generic of Pfizer’s Revatio for oral suspension which is currently listed on the FDA’s drug shortages list.
Use of the dry powder formulation of treprostinil, known as LIQ861, has demonstrated safety and tolerability in patients with pulmonary arterial hypertension beyond 2 weeks.
The cardiopulmonary reserve index is an effective predictor of prognosis in patients with pulmonary hypertension, particularly when pulmonary hypertension is caused by left heart disease.
The prognosis for patients with idiopathic pulmonary arterial hypertension is substantially worse than for patients with idiopathic PAH.